AstraZeneca

AstraZenecaAstraZeneca is a global, innovation-driven biopharmaceutical business with a primary focus on the discovery, development and commercialisation of prescription medicines. As a leader in gastrointestinal, cardiovascular, neuroscience, respiratory and inflammation, oncology and infectious disease medicines, AstraZeneca generated global revenues of US $32.8 billion in 2009. For more information please visit: www.astrazeneca.com.

AstraZeneca RSS Channel

Title Filter      Display #  
# Article Title
1 AstraZeneca to acquire rights to Actavis’ branded respiratory portfolio in the US and Canada
2 AstraZeneca announces collaborations to use CRISPR technology for genome editing across its drug discovery platform
3 MedImmune enters licensing agreement with Omnis Pharmaceuticals for oncolytic viruses in immuno-oncology
4 Jury verdict favours AstraZeneca in Nexium antitrust litigation
5 Amgen and AstraZeneca announce positive results from third and final pivotal Phase III study of Brodalumab in patients with moderate-to-severe plaque psoriasis
6 AstraZeneca announces initiation of development programme for BRILINTA® reversal agent
7 AstraZeneca launches Healthy Heart Africa programme to address hypertension in Africa
8 AstraZeneca strengthens partnership with the University of Cambridge
9 Positive results from Phase IIb benralizumab study in severe asthma
10 MedImmune and Cancer Research UK establish joint CRUK-MEDI Alliance Laboratory
11 AstraZeneca and Lilly announce alliance to develop and commercialise BACE inhibitor AZD3293 for Alzheimer's disease
12 AstraZeneca and Redx Pharma agree research collaboration
13 New data indicates Brilinta/Brilique™ has the flexibility to be initiated pre-hospital or in hospital in STEMI patients
14 United States Department of Justice closes investigation into PLATO clinical trial for Brilinta
15 AstraZeneca agrees strategic transaction with Almirall in respiratory disease
16 MedImmune and Advaxis partner on immuno-oncology combination clinical trial
17 AstraZeneca reveals designs for new Global R&D Centre and Corporate Headquarters in Cambridge, UK
18 AstraZeneca and Max Planck Institute announce research agreement
19 AstraZeneca updates on the rapid progress of its oncology pipeline at ASCO 2014
20 Clarification regarding Pfizer statement
World Pharma News RSS Channel
Subscribe to World Pharma News by Email

Follow/Join us on:   Facebook   Twitter   XING   LinkedIn   Google Groups    FeedBurner

Pharmaceutical Companies

[ A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Z ]